Dr. Barry Dworkin

Proof-of-concept succeeds in producing functional 3D-printed heart tissue and anatomical architecture but clinical application requires many trials in animal models before considering human ones.

Health Headlines Commentary for April 16, 2019

Source:

Tiny heart 3-D-printed using patient’s own cells, paving way for ‘fully personalized’ transplants

Reference:

3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts

Related posts:

  1. MIT develops nanogel for improved drug delivery to damaged tissues. Study needs to move onto human trials
  2. Injectable polymer demonstrates ability to stop severe bleeding after traumatic injury in rats
  3. Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.
  4. Study succeeds at restoring selected molecular and cellular processes across multiple vital organs after death in pigs. Far from human use and a plethora of bioethical questions remain to be addressed.